Skip to main content
Erschienen in: Heart and Vessels 5/2014

01.09.2014 | Original Article

Gender differences in factors influencing electrocardiographic findings of left ventricular hypertrophy in severe aortic stenosis

verfasst von: Shinji Satoh, Soichiro Omura, Hiroko Inoue, Emiko Ejima, Koutatsu Shimozono, Makiko Hayashi, Takahiro Mori, Katsuhiko Takenaka, Natsumi Kawamura, Kotaro Numaguchi, Etsuo Mori, Akemi Asoh, Toshihiro Nakamura, Koji Hiyamuta

Erschienen in: Heart and Vessels | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

We investigated gender differences in factors influencing the electrocardiographic (ECG) findings of left ventricular hypertrophy (LVH) in patients with severe aortic stenosis (AS). The functional and geometric responses of the left ventricle to chronic pressure overload, such as hypertension and AS, have been reported to be different between men and women. However, gender differences in the factors influencing the ECG findings of LVH in pressure overload remain unknown. We conducted a retrospective observational study in consecutive patients with severe AS (aortic valve area (AVA) assessed by cardiac catheterization <1.0 cm2) without concomitant significant aortic regurgitation, mitral stenosis and/or regurgitation, conduction disturbance, or myocardial infarction (n = 35 males, 68 females). The ECG criteria were classified into three categories: (1) high voltage by the Sokolow–Lyon index associated with ST-T wave changes (with no digitalis therapy); (2) high voltage alone; and (3) normal. Groups 1 and 2 were defined as LVH on ECG. We compared the ECG findings in relation to the AS severity between genders. Women were older, but there were no significant differences in the prevalence of hypertension, AVA index (AVAI), mean pressure gradient or peak velocity across the AV, LV mass index (LVMI) derived from echocardiography or the distribution of ECG categories between genders. A multiple logistic regression analysis including age, gender, hypertension, AVAI, mean pressure gradient, and LVMI revealed that the LVMI (P = 0.001) and AVAI (P = 0.0434) were significantly related to the distribution of ECG categories. LVMI significantly predicted LVH on ECG in both genders, but AVAI was a predictive factor in only women. ECG LVH in patients with severe AS may be mainly reflected by LVMI in men and by both LVMI and AVAI in women. Factors other than AVA, such as end-stage disease and/or complicating factors such as hypertension, may underlie the observed differences in ECG findings of LVH between men and women.
Literatur
1.
Zurück zum Zitat Mizia-Stec K, Lasota B, Mizia M, Chmiel A, Adamczyk T, Chudek J, Gasior Z (2012) Copeptin constitutes a novel biomarker of degenerative aortic stenosis. Heart Vessels. doi:10.1007/s00380-00012-00293-y Mizia-Stec K, Lasota B, Mizia M, Chmiel A, Adamczyk T, Chudek J, Gasior Z (2012) Copeptin constitutes a novel biomarker of degenerative aortic stenosis. Heart Vessels. doi:10.​1007/​s00380-00012-00293-y
2.
Zurück zum Zitat Siegel RJ, Roberts WC (1982) Electrocardiographic observations in severe aortic stenosis: correlative necropsy study to clinical, hemodynamic, and ECG variables demonstrating relation of 12-lead QRS amplitude to peak systolic transaortic pressure gradient. Am Heart J 103:210–221PubMedCrossRef Siegel RJ, Roberts WC (1982) Electrocardiographic observations in severe aortic stenosis: correlative necropsy study to clinical, hemodynamic, and ECG variables demonstrating relation of 12-lead QRS amplitude to peak systolic transaortic pressure gradient. Am Heart J 103:210–221PubMedCrossRef
3.
Zurück zum Zitat Casale PN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, Phillips MC (1985) Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol 6:572–580PubMedCrossRef Casale PN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, Phillips MC (1985) Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol 6:572–580PubMedCrossRef
4.
Zurück zum Zitat Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes Jr, Feinleib M, Castelli WP (1987) The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 75 (suppl I):I-26–I-33 Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes Jr, Feinleib M, Castelli WP (1987) The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 75 (suppl I):I-26–I-33
5.
Zurück zum Zitat Okin PM, Roman MJ, Devereux RB, Kligfield P (1995) Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 25:417–423PubMedCrossRef Okin PM, Roman MJ, Devereux RB, Kligfield P (1995) Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 25:417–423PubMedCrossRef
6.
Zurück zum Zitat Norman JEJ, Levy D (1995) Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach. J Am Coll Cardiol 26:1022–1029PubMedCrossRef Norman JEJ, Levy D (1995) Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach. J Am Coll Cardiol 26:1022–1029PubMedCrossRef
7.
Zurück zum Zitat Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M (2004) New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension 44:175–179PubMedCrossRef Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M (2004) New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension 44:175–179PubMedCrossRef
8.
Zurück zum Zitat Okin PM, Gerdts E, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, Devereux RB, for the Losartan Intervention for Endpoint Reduction in Hypertension Study Investigators (2008) Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy. Hypertension 52:100–106PubMedCrossRef Okin PM, Gerdts E, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, Devereux RB, for the Losartan Intervention for Endpoint Reduction in Hypertension Study Investigators (2008) Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy. Hypertension 52:100–106PubMedCrossRef
9.
Zurück zum Zitat Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JH (1986) The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 7:639–650PubMedCrossRef Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JH (1986) The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 7:639–650PubMedCrossRef
10.
Zurück zum Zitat Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, Grimm R, Stamler J (1993) Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 87:476–486PubMedCrossRef Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, Grimm R, Stamler J (1993) Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 87:476–486PubMedCrossRef
11.
Zurück zum Zitat Aurigemma GP, Silver KH, McLaughlin M, Mauser J, Gaasch WH (1994) Impact of chamber geometry and gender on left ventricular systolic function in patients >60 years of age with aortic stenosis. Am J Cardiol 74:794–798PubMedCrossRef Aurigemma GP, Silver KH, McLaughlin M, Mauser J, Gaasch WH (1994) Impact of chamber geometry and gender on left ventricular systolic function in patients >60 years of age with aortic stenosis. Am J Cardiol 74:794–798PubMedCrossRef
12.
Zurück zum Zitat Douglas PS, Otto CM, Mickel MC, Labovitz A, Reid CL, Davis KB (1995) Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry. Br Heart J 73:548–554PubMedCrossRefPubMedCentral Douglas PS, Otto CM, Mickel MC, Labovitz A, Reid CL, Davis KB (1995) Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry. Br Heart J 73:548–554PubMedCrossRefPubMedCentral
13.
Zurück zum Zitat Rohde LE, Zhi G, Aranki SF, Beckel NE, Lee RT, Reimold SC (1997) Gender-associated differences in left ventricular geometry in patients with aortic valve disease and effect of distinct overload subsets. Am J Cardiol 80:475–480PubMedCrossRef Rohde LE, Zhi G, Aranki SF, Beckel NE, Lee RT, Reimold SC (1997) Gender-associated differences in left ventricular geometry in patients with aortic valve disease and effect of distinct overload subsets. Am J Cardiol 80:475–480PubMedCrossRef
14.
Zurück zum Zitat Vriz O, Lu H, Visentin P, Nicolosi L, Mos L, Palatini P (1997) Gender differences in the relationship between left ventricular size and ambulatory blood pressure in borderline hypertension. The HARVEST Study. Eur Heart J 18:664–670PubMedCrossRef Vriz O, Lu H, Visentin P, Nicolosi L, Mos L, Palatini P (1997) Gender differences in the relationship between left ventricular size and ambulatory blood pressure in borderline hypertension. The HARVEST Study. Eur Heart J 18:664–670PubMedCrossRef
15.
Zurück zum Zitat Milavetz DL, Hayes SN, Weston SA, Seward JB, Mullany CJ, Roger VL (2000) Sex differences in left ventricular geometry in aortic stenosis. Chest 117:1094–1099PubMedCrossRef Milavetz DL, Hayes SN, Weston SA, Seward JB, Mullany CJ, Roger VL (2000) Sex differences in left ventricular geometry in aortic stenosis. Chest 117:1094–1099PubMedCrossRef
16.
Zurück zum Zitat Luchner A, Bröckel U, Muscholl M, Hense HW, Döring A, Riegger GA, Schunkert H (2002) Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc Res 53:720–727PubMedCrossRef Luchner A, Bröckel U, Muscholl M, Hense HW, Döring A, Riegger GA, Schunkert H (2002) Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc Res 53:720–727PubMedCrossRef
17.
Zurück zum Zitat Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, Karp RB (1992) Sex-associated differences in left ventricular function in aortic stenosis in the elderly. Circulation 86:1099–1107PubMedCrossRef Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, Karp RB (1992) Sex-associated differences in left ventricular function in aortic stenosis in the elderly. Circulation 86:1099–1107PubMedCrossRef
18.
Zurück zum Zitat Morris JJ, Schaff HV, Mullany CJ, Morris PB, Frye RL, Orszulak TA (1994) Gender differences in left ventricular function response to aortic valve replacement. Circulation 90(part 2):II-183–II-189 Morris JJ, Schaff HV, Mullany CJ, Morris PB, Frye RL, Orszulak TA (1994) Gender differences in left ventricular function response to aortic valve replacement. Circulation 90(part 2):II-183–II-189
19.
Zurück zum Zitat Villari B, Campbell SE, Schneider J, Vassalli G, Chiariello M, Hess OM (1995) Sex-dependent differences in left ventricular function and structure in chronic pressure overload. Eur Heart J 16:1410–1419PubMed Villari B, Campbell SE, Schneider J, Vassalli G, Chiariello M, Hess OM (1995) Sex-dependent differences in left ventricular function and structure in chronic pressure overload. Eur Heart J 16:1410–1419PubMed
20.
Zurück zum Zitat Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Hammer-Hansen S, Køber L, Willenheimer R, Wachtell K (2011) Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data). Am J Cardiol 108:541–547PubMedCrossRef Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Hammer-Hansen S, Køber L, Willenheimer R, Wachtell K (2011) Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data). Am J Cardiol 108:541–547PubMedCrossRef
21.
Zurück zum Zitat Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K (2012) Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study. Circulation 125:346–353PubMedCrossRef Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K (2012) Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study. Circulation 125:346–353PubMedCrossRef
22.
Zurück zum Zitat Okin PM, Roman MJ, Devereux RB, Kligfield P (1995) Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension 25:242–249PubMedCrossRef Okin PM, Roman MJ, Devereux RB, Kligfield P (1995) Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension 25:242–249PubMedCrossRef
23.
Zurück zum Zitat Bonow RO, Carabello BA, Chatterjee K, de Leon ACJ, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SCJ, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114:e84–e231PubMedCrossRef Bonow RO, Carabello BA, Chatterjee K, de Leon ACJ, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SCJ, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114:e84–e231PubMedCrossRef
24.
Zurück zum Zitat Sokolow M, Lyon T (1949) The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 37:161–186PubMedCrossRef Sokolow M, Lyon T (1949) The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 37:161–186PubMedCrossRef
25.
Zurück zum Zitat Devereux RB, Daniel R, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Irene Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57:450–458PubMedCrossRef Devereux RB, Daniel R, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Irene Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57:450–458PubMedCrossRef
26.
Zurück zum Zitat Legget ME, Kuusisto J, Healy NL, Fujioka M, Schwaegler RG, Otto CM (1996) Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis. Am Heart J 131:94–100PubMedCrossRef Legget ME, Kuusisto J, Healy NL, Fujioka M, Schwaegler RG, Otto CM (1996) Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis. Am Heart J 131:94–100PubMedCrossRef
27.
Zurück zum Zitat Krumholz HM, Larson M, Levy D (1993) Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 72:310–313PubMedCrossRef Krumholz HM, Larson M, Levy D (1993) Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 72:310–313PubMedCrossRef
28.
Zurück zum Zitat Nakamura H, Kurokawa J, Bai CX, Asada K, Xu J, Oren RV, Zhu Z, Clancy CE, Isobe M, Furukawa T (2007) Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation 116:2913–2922PubMedCrossRef Nakamura H, Kurokawa J, Bai CX, Asada K, Xu J, Oren RV, Zhu Z, Clancy CE, Isobe M, Furukawa T (2007) Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation 116:2913–2922PubMedCrossRef
29.
Zurück zum Zitat Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T (2005) Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 112:1701–1710PubMedCrossRef Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T (2005) Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 112:1701–1710PubMedCrossRef
30.
Zurück zum Zitat Kurokawa J, Suzuki T, Furukawa T (2009) New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: acute effects of female hormones on cardiac ion channels and cardiac repolarization. J Pharmacol Sci 109:334–340PubMedCrossRef Kurokawa J, Suzuki T, Furukawa T (2009) New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: acute effects of female hormones on cardiac ion channels and cardiac repolarization. J Pharmacol Sci 109:334–340PubMedCrossRef
Metadaten
Titel
Gender differences in factors influencing electrocardiographic findings of left ventricular hypertrophy in severe aortic stenosis
verfasst von
Shinji Satoh
Soichiro Omura
Hiroko Inoue
Emiko Ejima
Koutatsu Shimozono
Makiko Hayashi
Takahiro Mori
Katsuhiko Takenaka
Natsumi Kawamura
Kotaro Numaguchi
Etsuo Mori
Akemi Asoh
Toshihiro Nakamura
Koji Hiyamuta
Publikationsdatum
01.09.2014
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 5/2014
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-013-0397-z

Weitere Artikel der Ausgabe 5/2014

Heart and Vessels 5/2014 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.